Clinical Trial Update: Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety of a lyophilized RSV mRNA vaccine, sponsored by Sinovac Biotech, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV mRNA vaccine (lyophilized)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: RSV, mRNA Vaccine | Phase 1 | Status: NOT_YET_RECRUITING